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The localization of tail-anchored (TA) proteins, whose transmem-
brane domain resides at the extreme C terminus, presents major
challenges to cellular protein targeting machineries. In eukaryotic
cells, the highly conserved ATPase, guided entry of tail-anchored
protein 3 (Get3), coordinates the delivery of TA proteins to the
endoplasmic reticulum. How Get3 uses its ATPase cycle to drive
this fundamental process remains unclear. Here, we establish
a quantitative framework for the Get3 ATPase cycle and show that
ATP speciﬁcally induces multiple conformational changes in Get3
that culminate in its ATPase activation through tetramerization.
Further, upstream and downstream components actively regulate
the Get3 ATPase cycle to ensure the precise timing of ATP hydro-
lysis in the pathway: the Get4/5 TA loading complex locks Get3 in
the ATP-bound state and primes it for TA protein capture, whereas
the TA substrate induces tetramerization of Get3 and activates its
ATPase reaction 100-fold. Our results establish a precise model for
how Get3 harnesses the energy from ATP to drive the membrane
localization of TA proteins and illustrate how dimerization-activated
nucleotide hydrolases regulate diverse cellular processes.
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Proper localization of membrane proteins is essential for thestructure and function of all cells. Tail-anchored (TA)
proteins, which contain a single transmembrane domain at their
extreme C terminus, comprise 3–5% of the membrane proteome
(1) and mediate diverse cellular processes including protein
translocation, vesicular transport, and protein quality control (1,
2). Due to their topology, TA proteins cannot engage cotransla-
tional protein targeting machineries and instead, must use post-
translational mechanisms for efﬁcient and accurate delivery to the
target membrane (1, 3).
In the guided entry of tail-anchored protein (GET) pathway,
a complex protein interaction cascade delivers TA proteins to
the endoplasmic reticulum (ER) (1, 2, 4, 5). TA proteins are
initially captured by the cochaperone Sgt2 in yeast (6, 7) or the
BAG6 complex in mammalian cells (8). The Get4/5 complex (or
its mammalian homolog TRC35/Ubl4a), which binds both Sgt2
(or Bag6) and the Get3 ATPase (or its mammalian homolog
TRC40) (5, 9), then enables the loading of TA protein from Sgt2
onto Get3, the central ATPase in the pathway (6, 10). The Get3/
TA complex then binds its receptor, the Get1/2 complex on the
ER membrane, upon which the TA protein is released from
Get3 and inserted into the membrane (5, 11, 12).
TA protein insertion is an ATP-dependent process (3) driven
by Get3/TRC40, an obligate ATPase homodimer (4, 5, 13–15).
Twenty-one Get3 structures, solved in various nucleotide states,
show that nucleotide occupancy in the Get3 ATPase domain
allows adjustments at its dimer interface that are ampliﬁed into
larger displacements of its helical domains. This leads to various
structures, from open conformations in apo-Get3 in which the
helical subdomains are separated, to more closed conformations
in adenylyl imidodiphosphate or ADP·AlF4
–-bound Get3 in
which the helical domains form a contiguous hydrophobic groove
proposed to mediate TA protein binding (14–18). Further, the
Get1 cytosolic domain preferentially binds apo-, open Get3 (11,
12, 19), strongly suggesting that Get1 promotes the release of
nucleotide and TA proteins from Get3 at the end of the
targeting cycle.
Despite rich structural information, many key questions remain
regarding how the Get3 ATPase cycle drives the efﬁcient delivery
of TA proteins. First, when, where, and how ATP binding and
hydrolysis occur in the GET pathway has been unclear. Second,
ADP-bound Get3 has been solved in both open and closed struc-
tures (14, 18), raising questions as to the speciﬁcity of Get3 in
recognizing nucleotides and generating nucleotide-driven confor-
mational changes. Third, the nucleotide states of Get3 required for
interacting with Get4/5 or for Get4/5-mediated loading of TA
proteins remain controversial (6, 10, 20). Most importantly, models
based on a two-state open-to-closed transition are insufﬁcient to
explain the complex cascade of protein interactions that must be
coordinated by Get3, which requires multiple functional states in
this ATPase.
The requirement for the Sgt2·Get4/5 complex in the GET
pathway raises additional questions. Why is Get3 unable to di-
rectly capture the TA substrate? How does the Get4/5 complex
drive the transfer of TA proteins to Get3? Thus far, Get4/5
appears to be nothing more than a scaffold that brings Sgt2 and
Get3 into close proximity. Whether Get4/5 can actively facilitate
TA protein capture by Get3 is unclear.
Finally, whereas the predominant model for TA protein
binding invokes a closed Get3 dimer (14), there is also evidence
for a tetrameric Get3 complex: recombinant Get3/TA complexes
are predominantly tetramers in size exclusion chromatography,
and several archaeal Get3 homologs form obligate tetramers (16,
21). Whether and how a Get3 tetramer functions in TA protein
targeting remain unclear.
To address these questions, here we establish a quantitative
framework for the ATPase cycle of Saccharomyces cerevisiae (Sc)
Get3. We demonstrate that Get4/5 and the TA protein substrate
actively regulate this cycle to ensure the precise timing of ATP
hydrolysis. These results provide an explicit model for how Get3’s
ATPase cycle is coupled to conformational changes that drive TA
protein targeting.
Results
Cooperative ATP Binding to Get3. We began by establishing a quan-
titative framework for the Get3 ATPase cycle (Fig. 1). To probe
for nucleotide-driven conformational changes, we compared
Get3’s activity under two conditions: (i) “Single-site” conditions, in
which Get3 is in 10- to 1,000-fold excess over the nucleotide so that
statistically, the majority of nucleotide-bound Get3 dimers have
a single ATPase site occupied; and (ii) “multi-site” conditions, in
which the nucleotide is in excess over Get3 so that both ATPase
sites are occupied. Nucleotide binding to Get3 is measured using
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both ATPase assays (Fig. 2A and Fig. S1A) and direct measure-
ments based on changes in anisotropy of the ﬂuorescent ATP
analog 2′-/3′-O-(N′-methylanthraniloyl)-ATP (mantATP) (Fig.
2B). Under single-site conditions, Get3 binds ATP weakly and
displays no discrimination between ATP and ADP (Fig. 1, Fig. 2 A
and B, and Table S1, K1 and K9). In contrast, under multi-site
conditions Get3’s ATPase reaction exhibited a cooperative de-
pendence on ATP concentration, giving a Hill coefﬁcient of 2 and
a ∼10-fold higher afﬁnity for binding of the second ATP (Figs. 1
and 2C and Table S1, K3).
To test the speciﬁcity of this cooperative effect, we directly
measured the rates of nucleotide binding to and release from
Get3 using: (i) environmentally sensitive changes in mantATP
under single-site conditions (Fig. S1B), and (ii) FRET between
a native tryptophan in Get3 and mantATP under multi-site
conditions (Fig. S1C) (12). These measurements show that ATP
binds twofold faster and dissociates threefold more slowly under
multi-site conditions (Fig. 2D and Fig. S2, black; Fig. 1 and Table
S1, k1, k−1 vs. k3, k−3), providing independent support for co-
operative ATP binding to Get3. This cooperativity is speciﬁc for
ATP: compared with single-site conditions, the rate of mantADP
binding was unchanged, and ADP release is over threefold faster
under multi-site conditions (Fig. 2D and Fig. S2, gold; Fig. 1 and
Table S1, k8, k−8 vs. k9, k−9), indicating that Get3 disfavors ADP
occupancy at both active sites. Together, these results show that
ATP speciﬁcally induces rearrangements in Get3 that lead to
stronger binding of the second ATP molecule (Fig. 1, steps 1 and
3), whereas ADP does not (Fig. 1, step 8).
Tetramerization of Get3 Activates ATP Hydrolysis and Is Required for
TA Protein Targeting. Unexpectedly, the observed ATPase rate
constant at saturating ATP concentrations, or kcat, rises with in-
creasing Get3 concentration (Figs. 2C and 3A). This phenomenon
was observed even in the presence of BSA, an effective surfactant
and crowding reagent, suggesting that it is unlikely to be caused by
enzyme loss or inactivation at low concentrations (Fig. S3A). In-
stead, this result suggests that an oligomerization process stim-
ulates Get3’s ATPase activity. Quantitatively, these data are most
consistent with a model in which dimeric Get3 is in dynamic
equilibrium (Kd = 3.5 ± 1.9 μM) with tetrameric Get3, which
hydrolyzes ATP faster than dimeric Get3 (Fig. 1, steps 5–7 and
Eq. S9). Analysis of the data based on this model yielded a kcat
value for tetrameric Get3 of 1.3 ± 0.4 min−1 (Fig. 1 and Table S1,
k6), over 100-fold faster than dimeric Get3 (Fig. 3A and Fig. S3A;
Fig. 1 and Table S1, k4). This phenomenon has previously escaped
detection, likely because it is abolished in less physiological so-
lution conditions (Fig. S3B), whereas our ATPase measurements
used the same buffer as for protein targeting/translocation reac-
tions (22). The transient nature of tetrameric Get3 could also
render it susceptible to dissociation during size exclusion chro-
matography (23).
In a structure of theMethanocaldococcus jannaschii (Mj) Get3
tetramer, helix 8 plays a key role in stabilizing the tetramer in-
terface. Mutations of conserved hydrophobic residues in this
helix, F192D, M193D, and M196D, destabilize the tetramer (21).
To independently test whether tetramerization of ScGet3 is re-
sponsible for ATPase activation, we mutated homologous resi-
dues in ScGet3 (P199D/M200D, M200D/L201D; Fig. 3B). Given
their location, these mutations are unlikely to affect the TA
binding groove of the dimer, but would speciﬁcally disfavor the
formation or conformation of the tetramer. These mutations
reduced activated ATP hydrolysis at high Get3 concentrations to
almost the same extent as mutant Δ181–210, a negative control
that lacks a large portion of the putative TA-binding groove (Fig.
3 A and B) and completely abolished TA protein capture and
targeting (Fig. S4D). In contrast, the kcat values at low Get3
concentrations, where it is primarily a dimer, were largely un-
changed in these mutants (Fig. 3A). As additional controls, we
mutated residues in the putative TA binding groove of ScGet3
in the dimer model (F190D or I193D) (14). In contrast to the
mutants designed to disrupt the tetramer, F190D and I193D
exhibit over 10-fold higher ATPase activity and tetramerize more
favorably than wild-type Get3 (Fig. S3C and Table S2). These
results provide independent evidence that formation of a Get3
tetramer is required for activated ATP hydrolysis.
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Fig. 1. Model for the ATPase cycle of Get3. T denotes ATP; D denotes ADP.
Shapes depict various Get3 conformations: steps 1 and 2, ATP binding and
hydrolysis by a single active site in Get3; step 3, ATP binding to a second
active site of Get3; step 4, ATP hydrolysis from dimeric Get3; step 5, for-
mation of the Get3 tetramer; steps 6 and 7, ATP hydrolysis and ADP release
from tetrameric Get3; steps 8 and 9, release of ADP from the two active sites
of Get3. Individual rate and equilibrium constants are listed in Table S1.
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Fig. 2. Cooperative ATP binding to Get3. (A) Single-site ATP hydrolysis by
Get3. Data were ﬁt to Eq. S7 and they gave a KM of 37 ± 6.7 μM. (B) Equi-
librium titration of mantATP (0.3 μM, black) and mantADP (0.3 μM, gold)
binding to Get3 under single-site conditions. Data were ﬁt to Eq. S1. (C) ATP
hydrolysis by Get3 under multi-site conditions. Data were ﬁt to Eq. S8 and
they gave a Hill coefﬁcient of 2, average KM values of 3.0 ± 0.2, 3.6 ± 1.0, and
4.8 ± 0.2 μM, and observed kcat values of 0.26 ± 0.02, 0.33 ± 0.03, and 0.58 ±
0.03 min−1, respectively, for reactions with 0.2 (purple), 0.5 (blue), or 1.0
(black) μMGet3. (D) Summary of nucleotide binding and release kinetics. See
also Table S1.
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If tetramerization of Get3 and its associated ATPase activation
were important, it would also be manifested in a targeting reaction.
To test this hypothesis, we quantitatively measured the targeting
and translocation of a TA substrate, Sbh1p, to ER microsomes
(Fig. S4A). An NXT glycosylation site was engineered into the C
terminus of Sbh1p, whose glycosylation reports on successful
translocation across the membrane. Both the translation lysate and
ER microsomes were derived from a Δget3 strain, so that Sbh1p
targeting is dependent solely on exogenously added Get3. The
efﬁciency of Sbh1p targeting and translocation exhibited a co-
operative dependence on Get3 concentration with a Hill co-
efﬁcient of 2 (Fig. 3C and Fig. S4B), suggesting that efﬁcient
targeting requires two Get3 dimers to further associate to form
a tetramer. Additionally, mutants P199D/M200D and M200D/
L201D exhibit defects in targeting (Fig. 3D and Fig. S4C) that
quantitatively correlate with their defects in tetramerization-
induced ATPase activation (Fig. 3D). Combined with previous
observations that mutants M200D and L201D are deﬁcient in
TA substrate binding and supporting cell growth (14), these results
provide strong evidence that transient formation of a Get3 tetra-
mer is required for efﬁcient TA protein targeting.
Get4/5 Enhances ATP Binding but Inhibits ATP Hydrolysis by Get3.We
next asked how the Get4/5 complex, which acts as a scaffold to
facilitate TA protein loading from Sgt2 onto Get3, regulates the
Get3 ATPase. Intriguingly, Get4/5 stoichometrically inhibits
the ATPase activity of Get3 (Fig. 4A and Fig. S5A). Analysis
of the ATP concentration dependence of the reaction showed
that the average KM value is lowered to 1.4 ± 0.3 μM with Get4/5
present, indicating that Get3 binds ATP more strongly when it is
bound to Get4/5 (Fig. 4B and Fig. S5B). In contrast, Get4/5 reduced
the value of kcat, indicating speciﬁc inhibition of ATP hydrolysis
(Fig. 4B). Thus, Get4/5 induces Get3 into an alternative confor-
mation in which ATP is bound more tightly but held in a catalyti-
cally compromised structure.
To provide independent evidence for this model, we tested
how Get4/5 alters nucleotide binding of Get3 using the FRET
assay. Get4/5 did not affect the rate of ATP binding to Get3 (Fig.
4C) but reduced the rate of ATP dissociation from Get3 at least
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Fig. 3. Tetramerization stimulates Get3’s ATPase activity and is required for
TA protein targeting. (A) Observed kcat values as a function of Get3 con-
centration, for wild-type Get3 (black) and mutants Δ181–210 (green), P199D/
M200D (pink), and M200D/L201D (blue). Data were ﬁt to Eq. S9 and sum-
marized in D. (B) Structure of ScGet3 (Protein Data Bank: 3A36) highlighting
the residues mutated. The remainder of residues 181–210 is in green. (C)
Targeting and insertion of Sbh1p by wild-type Get3. Data were ﬁt to Eq. S11
and they gave a Hill coefﬁcient of 2. (D) Comparison of TA targeting efﬁ-
ciencies (open) and tetramer ATPase rate constants (ﬁlled) for wild-type
Get3 (black) and mutants P199D/M200D (pink), M200D/L201D (blue), and
Δ181–210 (green). Percent translocation was normalized to wild-type Get3.
Fig. 4. Get4/5 tightens ATP binding to Get3 and inhibits its ATPase activity.
(A) Get4/5 stoichiometrically inhibits Get3’s ATPase activity. Reaction con-
tained 0.5 μM Get3 and 10 μM ATP. (B) ATP concentration dependence of
ATPase activity at 0.5 μM Get3, with (red) or without (black) 5 μM Get4/5
present. Data were ﬁt to Eq. S8 and they gave average KM values of 3.7 ± 0.2
and 1.4 ± 0.3 μM with and without Get4/5, respectively. (C) Kinetics of
mantATP binding to Get3 with (red) and without (black) 3.0 μM Get4/5
present. Data were ﬁt to Eq. S4. (D) Dissociation of mantATP from Get3 was
slowed in the presence (red) of 3.0 μM Get4/5. (E) Observed kcat values as
a function of Get3 concentration with (red) or without (black) 50 μM Get4/5
present. Data with Get3 were analyzed as in Fig. 3A, and data with the
Get3·Get4/5 complex were ﬁt to a linear function. (F) Same as E but with
Get3 mutants F190D (triangles) and I193D (squares) with (red) or without
(black) Get4/5 present. Dotted lines are ﬁts for wild-type Get3 in E and
shown for comparison. All rate constants are reported in Tables S2 and S3.
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10-fold (Fig. 4D), providing direct evidence that Get3 binds ATP
more tightly when it is bound to Get4/5. This effect is speciﬁc for
ATP, as under the same conditions ADP release from Get3
remained fast and was largely unaffected by Get4/5 (Fig. S5C).
If Get4/5 induces stronger ATP binding to Get3, then ATP-
bound Get3 would also bind more strongly to Get4/5. To test
this prediction, we measured complex formation between Get3
and Get4/5 using gel ﬁltration chromatography. With apo-Get3,
complex assembly was not detected even at micromolar protein
concentrations (Fig. S5D). In contrast, with saturating ATP pres-
ent, almost all Get3 formed a complex with Get4/5 (Fig. S5E).
These results, although qualitative, are consistent with previous
pull-down experiments in which a stable Get3-4/5 complex was
enriched in the presence of nucleotides (6, 10, 20). Together,
these results show that Get4/5 preferentially binds ATP-loaded
Get3 and reciprocally, interaction with Get4/5 enables ATP to be
more tightly bound to Get3.
As the Get3 ATPase activity is activated upon tetramerization,
we asked whether Get4/5 inhibits this activation. Get4/5 also sto-
ichiometically inhibits the ATPase reaction at high Get3 concen-
trations, where it is predominantly a tetramer (Fig. S5A). With
saturating Get4/5 and ATP, the ATPase rate constant stayed
constant at 0.16 ± 0.07 min−1 and was independent of Get3 con-
centration (Fig. 4E). Thus, Get4/5 inhibits formation of the Get3
tetramer or the ATPase activation induced by tetramerization.
Mutants F190D and I193D exhibit higher ATPase activities
than wild-type Get3 in both the dimeric and tetrameric forms;
both of these activities are substantially reduced in the presence
of Get4/5 (Fig. 4F). Thus, these superactive mutant ATPases
provide stronger evidence that the ATPase activity of dimeric
Get3 is also inhibited by the Get4/5 complex.
TA Protein Induces Rapid ATP Hydrolysis and Locks Get3 in the ADP-
Bound State. We next asked how the TA protein substrate reg-
ulates the Get3 ATPase. To this end, we coexpressed Get3 with
Sbh1p. The Get3/Sbh1 complex puriﬁed predominantly as a tet-
rameric complex (Fig. S6A), consistent with previous observa-
tions (16, 21).
To determine the ATP hydrolysis rate from this complex, we
carried out presteady-state measurements using a high ATP
concentration and Get3 active sites in 1:5 stoichiometry relative
to ATP. Under these conditions, the ATPase reaction exhibited
two distinct kinetic phases: (i) an initial burst whose magnitude
increased with increasing Get3 concentration (Fig. 5A and Fig.
S6B), representing a rapid ﬁrst round of ATP hydrolysis; and (ii)
a slower linear phase representing subsequent rounds of ATP
turnover at steady state. The rate constant for the ﬁrst round of
ATP hydrolysis is 3.3 ± 1.1 min−1 (Eq. S10), over 100-fold faster
than that of the Get3 dimer. The rate constant for steady-state
ATP turnover is 0.055 ± 0.001 min−1, 60-fold slower than the
ﬁrst turnover. Thus, loading of TA protein onto Get3 activates
one round of ATP hydrolysis, but subsequent ATP turnover is
inhibited. Further, ATPase activation in the Get3/TA complex
was not observed under single-site conditions (compare Figs. 5B
and 2A), suggesting that it requires both Get3 active sites to be
bound with ATP. Finally, the magnitude of the burst phase is
stoichiometric with the concentration of Get3 active sites, sug-
gesting that all four ATPs in the Get3 tetramer are hydrolyzed
during the ﬁrst turnover.
To test whether nucleotide binding or release could be rate
limiting for the observed ATPase rates, we used the ﬂuorescence
assays to directly measure these events. MantATP binding to the
Get3/Sbh1 complex was slow and concentration independent at
the lowest concentrations tested under both multi-site (Fig. 5C
and Fig. S6C) and single-site conditions (Fig. S6D), suggesting
that a slow conformational change of the Get3/Sbh1 complex
becomes rate limiting for ATP binding. The rate of the domi-
nant, slow phase in ATP binding is similar to that of the burst
phase in the ATPase reaction (5.0 vs. 3.3 min−1), suggesting that
the ATPase rate constant observed here may still be limited by
a conformational change that precedes hydrolysis.
Remarkably, dissociation of ADP is at least 100-fold slower in
the Get3/Sbh1 complex compared with free Get3 (Fig. 5D and
Table S3) and is indistinguishable from that of ATP or non-
hydrolyzable ATP analogs (Fig. S6E and Table S3), suggesting
that the nucleotides are bound tightly and shielded from solvent
in this complex. Nevertheless, ADP release from the Get3/TA
complex is still 200-fold faster than the steady-state ATPase rate
and is unaffected by up to 10 mM inorganic phosphate (Fig. S6E
and Table S3). This indicates that an additional conformational
step, rather than product release, is rate limiting for steady-state
ATP turnover. Together, these data argue that only one round of
ATP hydrolysis occurs in the GET pathway, after which the
Get3/TA complex is locked in a catalytically inactive state loaded
with ADP, and disassembly of this complex would be needed to
reset its ATPase cycle.
Discussion
Efﬁcient and accurate delivery of membrane proteins often
requires energy input from nucleotide triphosphates, which in
the GET pathway is harnessed and used by the Get3 ATPase
(13, 24). When, where, and how ATP binding and hydrolysis
occur in the GET pathway remain open questions. Little is
known about how Get3’s nucleotide state, conformation, and
activity are regulated during TA protein targeting. Here, quanti-
tative mechanistic analyses deﬁne a precise framework for Get3’s
ATPase cycle and elucidate how it is used to drive this funda-
mental cellular process.
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Fig. 5. TA substrate induces rapid ATP hydrolysis. (A) Presteady-state
ATPase reaction at a 1:5 ratio of Get3/TA:ATP. The data were ﬁt to Eq. S10.
(B) ATP hydrolysis from the Get3/TA complex under single-turnover con-
ditions. Data were ﬁt to Eq. S7 and they gave a kcat value of 0.42 min
−1 and
a KM value of 33 μM. (C) Kinetics of mantATP binding to the Get3/TA com-
plex. Two phases were observed. The dashed part of the curve depicts the-
oretical increases in binding rates at lower ATP concentrations where
bimolecular association is rate limiting, but which was inaccessible in our
experiments. (D) MantADP dissociation from the Get3/TA complex. Data
with Get3 (black) were from Fig. S2F (black) and are shown for comparison.
All rate constants are reported in Table S3.
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Previous work showed that Get3’s ATPase domain acts as
a fulcrum at the dimer interface to generate a variety of structures
(13). The cooperative ATP binding observed here supports a
model in which Get3 changes from a largely open conformation
in apo-Get3 to increasingly closed conformations upon successive
ATP binding (Fig. 1, steps 1 and 3). Importantly, this coopera-
tivity is speciﬁc to ATP but not ADP. Thus, an ADP-bound Get3
dimer remains in a largely open conformation (15, 18), despite
the occasional observation of “closed”, ADP-bound Get3 struc-
tures (16). Nevertheless, the cooperativity induced by ATP is
fairly modest, ∼10-fold. Together with previous work (25), we
speculate that Get3 exists in an ensemble of conformations that
are in close equilibrium with one another, and each ATP binding
event induces a modest shift in the conformational landscape.
Thus, even the Get3 dimer bound with both ATPs is not com-
pletely closed, and is termed semiclosed here (Fig. 1).
Intriguingly, Get3 is catalytically activated through tetrameri-
zation (Fig. 1, steps 5 and 6). This phenomenon was previously
suggested by the structure of an MjGet3 tetramer and by the
formation of tetrameric Get3/TA complexes (21). Our ﬁndings
provide a function for tetrameric Get3, showing that it is the
active species for ATP hydrolysis and for efﬁcient TA protein
targeting. In further support of this model, hydrophobic residues
in helix 8 that stabilize the tetramer interface are conserved (15,
21); their mutations disrupt ATPase activation and protein tar-
geting by Get3 (this work) and lead to defects in cell viability and
TA binding (14, 21). Given the location of these residues, these
phenotypes are difﬁcult to reconcile with a dimeric model for
Get3. Although each of these observations can be explained by
alternative models, activation of Get3 via tetramerization pro-
vides a cohesive, unifying model that explains this diverse col-
lection of data.
In vivo, tetramerization of Get3 by itself should be disfavored
to minimize futile ATPase cycles. This could be achieved in part
by the low in vivo concentration of Get3, ∼1 μM (26), which is
below the Kd value for tetramerization (3.5 μM). The results here
further show that futile ATPase cycles of Get3 are minimized by
the Get4/5 complex, which mediates the loading of TA proteins
from Sgt2 onto Get3 (6, 10). Despite previous reports of Get4/5
binding to apo-Get3 (27), our results demonstrate that Get4/5
preferentially binds ATP-loaded Get3 and locks it in the ATP-
bound state (Fig. 6, step 2). This is achieved by tightening Get3’s
ATP binding but inhibiting its hydrolytic activity, particularly the
tetramerization-induced activation of ATP hydrolysis. Get4/5
could exert these effects by inducing Get3 into a distinct, “oc-
cluded” conformation in which its ATPase site is more closed but
incompetent for hydrolysis (Fig. 1). In addition, Get4/5 could
prevent Get3’s tetramerization. The latter model is particularly
attractive as it explains why Get5 is a stable dimer (28): a com-
plete Get4/5 complex could hold two closed Get3 dimers in the
ATP-bound state, priming them for subsequent tetramer for-
mation once the TA protein is loaded onto Get3 (Fig. 6, step 3).
Regardless of the model, our data show that Get4/5 is not
a passive scaffold that simply brings Sgt2 and Get3 into close
proximity. Rather, Get4/5 actively promotes TA protein loading
onto Get3 by locking it in the correct nucleotide state and
priming its conformation for TA substrate capture (6, 8).
In contrast to Get4/5, multiple lines of evidence strongly sug-
gest that the TA protein induces the tetramerization and activa-
tion of Get3’s ATPase activity (Fig. 6, step 3): (i) coexpression of
TA protein with Get3 results in a stable Get3 tetramer (this work
and refs. 16, 21); and (ii) rapid ATP hydrolysis was observed with
the Get3/TA complex, as would be expected for an activated Get3
tetramer. Several important lessons are learned from analysis of
the Get3/TA complex. First, after the ﬁrst round of ATP hydro-
lysis, subsequent ATP turnover is 60-fold slower and incompatible
with the time scale of protein targeting in vivo, arguing that only
one round of ATP hydrolysis occurs in the GET pathway. Second,
following ATP hydrolysis, Get3 is locked in a catalytically inactive
state. Together with observations with the Get3·Get4/5 complex,
these results demonstrate that the open-to-closed rearrangement
of Get3 can be conceptually and experimentally uncoupled: even
when Get3 is globally closed and nucleotide release is slow, ad-
ditional active site adjustments speciﬁcally regulate catalytic ac-
tivity. We speculate that this relates to local rearrangements of
the switch II loops (13), which provide multiple essential catalytic
residues. The ADP-bound MjGet3 tetramer structure possibly
provides a view of a closed but catalytically inactive Get3 tetra-
mer, in which the switch II loop is pulled away and incompatible
for hydrolysis (21). Finally, ADP release is substantially slowed in
the Get3/TA complex and becomes indistinguishable from that of
ATP, suggesting that the TA protein is dominant in inducing
a closed Get3 tetramer.
In the context of the targeting cycle, TA-induced Get3 tetra-
mer formation would be beneﬁcial as the hydrophobic trans-
membrane domain of the TA substrate can be completely
protected in a cage at the tetrameric interface (21), minimizing
its potential aggregation (Fig. 6). Our results also suggest that
following hydrolysis, ADP release from the Get3/TA complex
may be delayed until Get3 ﬁnds the Get1/2 membrane receptor.
Tetramer disassembly by this receptor would be needed to re-
lease the TA protein. As ATP and Get1 binding to Get3 are
strongly antagonistic with one another (10–12), ATP hydrolysis
in the Get3/TA complex likely primes it for disassembly at
the membrane.
Collectively, our results deﬁne a precise model for how the
Get3 ATPase cycle is used to drive TA protein targeting (Fig. 6).
Under cellular conditions, the majority of Get3 cooperatively
binds ATP at both active sites, which induces it into a semiclosed
conformation (step 1). ATP-loaded Get3 is preferentially cap-
tured by Get4/5, which brings Get3 into the vicinity of Sgt2 and
induces the Get3 dimer into an occluded conformation in which
it is further closed but ATP hydrolysis is delayed (step 2). In this
conﬁguration, Get3 is primed to capture the TA substrate from
Sgt2 (step 2). Loading of TA protein induces tetramerization of
Get3 (step 3), which might also drive dissociation of Get3 from
Get4/5. The tetrameric Get3/TA complex undergoes a rapid
round of ATP hydrolysis, giving a stable ADP-loaded complex
that binds its receptor, Get1/2, at the ER membrane (step 4).
Tetramer disassembly, ADP dissociation, and TA protein release
into the membrane are likely coupled, resulting in Get1 bound to
apo-Get3 in the open conformation (step 5). ATP binding then
releases Get3 from Get1 (10–12) to reinitiate the cycle.
Get3 is the only eukaryotic ATPase in the SIMIBI [for
signal recognition particle (SRP), MinD, and BioD] family of
deviant P-loop NTPases, including the SRP and SRP receptor
(SR) that mediate cotranslational protein targeting (29). Al-
though the details of each system differ, the results here reveal
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Fig. 6. Model for TA protein targeting driven by the ATPase cycle of Get3,
as described in the text.
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many similarities in the regulatory principles between Get3 and
SRP/SR. Both exhibit low nucleotide afﬁnity and forego the
need of external exchange factors and activating proteins as
regulatory elements (30). Instead, both use dimeric complexes
as the functional unit. As dimers, both undergo conforma-
tional changes on the global (open-to-closed transitions) and
local (catalytic loop adjustments) scale to generate multiple
functional states during an NTPase cycle. For both, these
rearrangements provide key regulatory points to sense and
respond to upstream and downstream components and effect
the precise timing of nucleotide hydrolysis in the pathway:
GTP hydrolysis in the SRP/SR complex is stalled by the
translation ribosome and reactivated by the SecYEG ma-
chinery (31, 32), whereas ATP hydrolysis in Get3 is stalled by
Get4/5 and activated by the TA substrate. Based on regulatory
principles, Get3 could be placed in the class of NTPases
regulated by dimerization (33) whose members, aside from
SRP and SR, also include the human GBP1, the septins,
HypB, MnmE, and the dynamin family of GTPases (33, 34). In-
vestigation of Get3 undoubtedly enhances our understanding
of the mechanism, regulation, and evolution of this ubiquitous
class of regulators.
Materials and Methods
Protein Expression and Puriﬁcation. Mutant Get3s were generated using
Quikchange Mutagenesis protocol (Stratagene). Wild-type and mutant Get3s
were expressed and puriﬁed as described (15, 20). Puriﬁcation of the Get4/5
and Get3/Sbh1 complexes is described in SI Materials and Methods.
Fluorescence Measurements. All ﬂuorescent nucleotides were from Jena
Biosciences. All measurements were carried out at 25 °C in Get3 assay buffer
(50 mM Hepes pH 7.4, 150 mM potassium acetate, 5 mM magnesium ace-
tate, 1 mM DTT, and 10% glycerol) using a Fluorolog-3–22 spectroﬂuo-
rometer (Jobin Yvon) or a Kintek stopped-ﬂow apparatus. Determination
of individual rate and equilibrium constants is described in SI Materials
and Methods and Fig. S7.
ATPase Assays. All reactions were performed in Get3 assay buffer at 25 °C
with [γ-32P]-ATP (MP Biomedicals). Reactions at Get3 concentrations below
0.5 μM also included 1 mg/mL BSA. Reactions were quenched in 0.75 M
potassium phosphate (pH 3.3), analyzed by polyethylenimine cellulose TLC in
1 M formic acid/ 0.5 M LiCl, and quantiﬁed by autoradiography. Observed
rate constants were obtained as described (35). Determination of in-
dividual rate and equilibrium constants is described in SI Materials
and Methods.
TA Protein Targeting and Translocation. Yeast translation extracts were pre-
pared as described (21, 36), except that an additional centrifugation step
(SW55Ti, 30 min at 291,000 × g) was included before chromatography on
the G25 column. Yeast microsomes were prepared as described (5, 37).
Translation and translocation of TA protein is detailed in SI Materials
and Methods.
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